Tampolay, Leah .
HRN: 23-65-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/03/2023
09/09/2023
IV
4.5
Q6
Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractBone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes